Not applicableStudy completedNCT00900302What this trial is testingOX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerWho this might be right forCancer OHSU Knight Cancer Institute 98
Testing effectiveness (Phase 2)Study completedNCT02399813What this trial is testingAxalimogene Filolisbac (ADXS11-001) in Participants With Carcinoma of the Anorectal CanalWho this might be right forAnal CancerRectal Cancer Advaxis, Inc. 36
Early research (Phase 1)Study completedNCT00019110What this trial is testingVaccine Therapy in Treating Patients With Advanced or Recurrent CancerWho this might be right forAnal CancerCervical CancerEsophageal Cancer+3 more National Cancer Institute (NCI)
Early research (Phase 1)Looking for participantsNCT06270706What this trial is testingPLN-101095 in Adults With Advanced or Metastatic Solid TumorsWho this might be right forAdvanced or Metastatic Solid Tumor Pliant Therapeutics, Inc. 124
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06505551What this trial is testingPhase 1/2 Study of Autologous SCG142 TCR T Cells in Patients With HPV16/52-positive CarcinomaWho this might be right forHPV-Related Squamous Cell CarcinomaHPV-Related Cervical Squamous Cell CarcinomaHPV-Related Vulvar Squamous Cell Carcinoma+4 more SCG Cell Therapy Pte. Ltd. 66
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Active Not RecruitingNCT07280377What this trial is testingA Study in Advanced or Metastatic Gastrointestinal Cancers Exploring Treatment Combinations With Pelareorep and AtezolizumabWho this might be right forAnal Cancer MetastaticSquamous Cell Carcinoma of the Anus Stage UnspecifiedPancreatic Cancer Metastatic+1 more Oncolytics Biotech 122
Early research (Phase 1)Study completedNCT00031681What this trial is testing7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)Who this might be right forAdvanced Adult Primary Liver CancerCarcinoma of the AppendixEstrogen Receptor-negative Breast Cancer+85 more National Cancer Institute (NCI) 41
Testing effectiveness (Phase 2)WithdrawnNCT04499352What this trial is testingTest BI 754091 Alone or in Combination With BI 836880 in People Who Have Advanced Anal CancerWho this might be right forAnal Canal Squamous Cell Carcinoma Boehringer Ingelheim
Testing effectiveness (Phase 2)UnknownNCT03944252What this trial is testingCetuximab + Avelumab or Avelumab Alone for Unresectable, Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (SCCAC) Progressed After at Least One Line of Systemic Treatment (CARACAS)Who this might be right forSquamous Cell Anal Carcinoma Gruppo Oncologico del Nord-Ovest 54
Testing effectiveness (Phase 2)Looking for participantsNCT04894370What this trial is testingCombination of Spartalizumab, mDCF and Radiotherapy in Patients With Metastatic Squamous Cell Anal CarcinomaWho this might be right forSquamous Cell Anal CarcinomaMetastatic Squamous Cell Carcinoma Centre Hospitalier Universitaire de Besancon 34
Testing effectiveness (Phase 2)Looking for participantsNCT07602842What this trial is testingIDP-001 in Advanced or Metastatic Solid TumorsWho this might be right forAdvanced Solid TumorMetastatic Solid TumorHead and Neck Squamous Cell Carcinoma+6 more InduPro, Inc. 132
Testing effectiveness (Phase 2)Study completedNCT02402842What this trial is testingClinical and Biological Interest of Taxanes in Advanced Squamous Cell Anal CarcinomaWho this might be right forAnal Canal Carcinoma Centre Hospitalier Universitaire de Besancon 70
Not applicableActive Not RecruitingNCT03712566What this trial is testingMulti-Omic Assessment of Squamous Cell Cancers Receiving Systemic TherapyWho this might be right forCancerEsophagus Squamous Cell CarcinomaSquamous Cell Carcinoma of the Head and Neck+2 more University Health Network, Toronto 39
Early research (Phase 1)Study completedNCT00397384What this trial is testingErlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal CancerWho this might be right forAdenocarcinoma of the ColonAdenocarcinoma of the RectumAdvanced Adult Primary Liver Cancer+64 more National Cancer Institute (NCI) 43
Early research (Phase 1)Study completedNCT00030498What this trial is testingErlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionWho this might be right forAdult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+83 more National Cancer Institute (NCI) 75
Testing effectiveness (Phase 2)Study completedNCT03519295What this trial is testingMDCF in Combination or Not With Atezolizumab in Advanced Squamous Cell Anal CarcinomaWho this might be right forAnal Cancer GERCOR - Multidisciplinary Oncology Cooperative Group 97
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)UnknownNCT02051868What this trial is testingInternational Multicentre Study in Advanced Anal Cancer Comparing Cisplatin Plus 5 FU vs Carboplatin Plus Weekly PaclitaxelWho this might be right forSquamous Cell Carcinoma of the Anus Royal Marsden NHS Foundation Trust 80
Early research (Phase 1)Active Not RecruitingNCT05973487What this trial is testingA Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid TumorsWho this might be right forHead and Neck CancerCervical CancerNon-small Cell Carcinoma+18 more TScan Therapeutics, Inc. 840